Regeneron Pharmaceuticals (REGN) EPS (Basic) Growth (3y) (2012 - 2026)
Regeneron Pharmaceuticals (REGN) EPS (Basic) Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -27.25% |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 139.68% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 25.99% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 85.94% |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 41.58% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.28% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | -2.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.92% |
| Dec 31, 2025 | -9.75% |
| Sep 30, 2025 | 4.60% |
| Jun 30, 2025 | 18.78% |
| Mar 31, 2025 | -5.98% |
| Dec 31, 2024 | -25.89% |
| Sep 30, 2024 | -6.91% |
| Jun 30, 2024 | -23.43% |
| Mar 31, 2024 | -14.13% |
| Dec 31, 2023 | -0.03% |
| Sep 30, 2023 | 5.91% |
| Jun 30, 2023 | 3.38% |
| Mar 31, 2023 | 10.32% |
| Dec 31, 2022 | 15.63% |
| Sep 30, 2022 | 26.23% |
| Jun 30, 2022 | 64.65% |
| Mar 31, 2022 | 29.19% |
| Dec 31, 2021 | 40.40% |
| Sep 30, 2021 | 40.85% |
| Jun 30, 2021 | 79.29% |